Showing results (1341-1350 of 2,669) with videos related to
Sort By:
Pageof 267
Oncology Research|January 1, 1997
Future challenges in the clinical development of thymidylate synthase inhibitor compoundsD S Brandt, E ChuOncology Research|January 1, 1997
Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinomaC Festuccia, A Teti, P Bianco, et al.Oncology Research|January 1, 1997
Specific histologic and cytogenetic evidence for in vivo malignant transformation of murine host cells by three human prostate cancer cell linesM Ozen, A S Multani, H Kuniyasu, et al.Oncology Research|January 1, 1997
Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cellsB A Spengler, D L Lazarova, R A Ross, et al.Oncology Research|January 1, 1997
Inhibitory effect of alkylating modulators on the function of P-glycoproteinJ M Yang, G F Sullivan, D B Makhey, et al.Oncology Research|January 1, 1997
Differential actions of aclarubicin and doxorubicin: the role of topoisomerase ID J Bridewell, G J Finlay, B C BaguleyOncology Research|January 1, 1997
Decreased vascular endothelial growth factor expression associated with tumor regression induced by (E)-2'-deoxy-2'-(fluoromethylene)cytidine (MDL 101,731)R D Woessner, D E Loudy, C D Wallace, et al.Oncology Research|January 1, 1997
Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell lineH Fujishima, S Nakano, N Masumoto, et al.Oncology Research|January 1, 1997
Heterogeneous expression of DNA topoisomerase II alpha isoforms in tumor cell linesY Y Mo, W T BeckPageof 267